You searched for "products"

1252 results found

PuroPro headphones review

The PuroPro is the latest product from Puro Sound Labs, a family-run business focusing on high quality, sound limiting headphones. For this family business, it’s personal. The company founder’s son has a noise-induced hearing loss attributed to headphone use. With...

Pollen forecasting apps: don’t worry, bee happy!

Hay fever sufferers rejoice! Around a fifth of people in the UK self-report to having hay fever (allergic rhinitis). In the majority of cases, this is thought to be a sensitivity to grass pollen. Symptoms may present as nasal congestion,...

Otology training in low- and middle-income countries: a view from within

It is recognised that hearing loss and ear disease are far more common in less affluent parts of the world, and that those countries are often least able to provide treatment; so how can we prioritise care for these patients?...

Kuduwave™ testing aboard the ISS

What does it take to make an audiometer and tympanometry ready for the space age? In a recent interview, Jillian Scotland and Dirk Koekemoer shared their first-hand experience of getting the Kuduwave ready for a voyage to the ISS. It...

In conversation with Julian Hamann

In recent years, there has been a definite shift toward the acceptance and use of smartphone technology in the delivery of healthcare. Within the fields of ENT and audiology, there is considerable appeal in the portability, simplicity, affordability, and connectivity...

BSFPS Annual Meeting 2025

British Society of Facial Plastic Surgery Juniors Day and Annual Meeting 2025

EUHA 2025: 69th International Congress of Hearing Aid Acousticians

EUHA 2025: 69th International Congress of Hearing Aid Acousticians will be held in Nuremberg, Germany, from 22 to 24 October 2025 We are building on last year's success and presenting our EUHA Live Area as a central meeting and networking area with special programme. It will be located in the Industry Exhibition. The event consists of a specialist conference featuring international lecturers and a trade fair with exhibitors from Germany and abroad. The EUHA Live Area connects the Congress and the Industry Exhibition even more closely. A central meeting and networking area with a stage will be created in the exhibition hall, where visitors can get information on the different topics.

Focus on ENT trainees with additional qualifications

In this Trainee Matters, we focus on ENT trainees with additional qualifications. Eight accomplished trainees tell Emma Stapleton how their achievements have benefitted them both professionally and personally. Their professional achievements have included a National Training Number in ENT, presentations,...

Adult Audiologic Rehabilitation – Third Edition

This book builds a vivid picture of adult audiologic rehabilitation in the past, present and future. It considers a holistic view of hearing rehabilitation and introduces new research and ideas which I hope will shape hearing services of the future....

Video- Based Aural Rehabilitation Guide

This book provides thorough coverage of vital topics within aural rehabilitation for children and adults. It targets a wide audience, including audiologists, speech therapists, Teachers of the Deaf and parents. It can also be used by clinicians supporting people with...

Genetics WG4. Improving diagnosis and drug development through the genetic understanding of tinnitus subtypes: a TINNET endeavour

Christopher R Cederroth and Jose Antonio Lopez-Escamez explain how progress is being made to investigate the contribution of genetic factors to tinnitus, including a subtype of ‘extreme’ tinnitus in Ménière’s disease. Genetics WG4 is working towards determining the genetic basis...

A place for everything and everything in its place: the practicalities of randomised clinical trials

Will this pill cure tinnitus? Bonnie Millar describes one trial that has investigated the possibility whilst describing the path of drug trials in the UK. Background In the last quarter of 2014, a clinical trial (QUIET-1; ClinicalTrials.gov Identifier: NCT02315508) commenced...